AACR Annual Meeting 2026
April 17–22, 2026 · San Diego · 2418 items
Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.
Page 3 No.41–60
Participants · trend · heat index- 41
TP53
7↓ 29%7↓ 29% - 42
#PDAC
6↓ 29%6↓ 29% - 43
FHD-909
6↓ 29%6↓ 29% - 44
#EPSTEINBARRVIRUS
6↓ 29%6↓ 29% - 45
#LYMPHOMA
6↓ 29%6↓ 29% - 46
leronlimab
6↓ 29%6↓ 29% - 47
#EOCRC
5↓ 30%5↓ 30% - 48
#LEGORRETACANCERCENTER
5↓ 30%5↓ 30% - 49
#COLORECTAL
5↓ 29%5↓ 29% - 50
#MMSM
5↓ 30%5↓ 30% - 51
#AGING
4↓ 30%4↓ 30% - 52
#SABCS25
4↓ 29%4↓ 29% - 53
#BIOPHARMA
4↓ 29%4↓ 29% - 54
#STJUDERESEARCH
4↓ 29%4↓ 29% - 55
trastuzumab
4↓ 30%4↓ 30% - 56
KEAP1
4↓ 30%4↓ 30% - 57
MET
3↓ 29%3↓ 29% - 58
#CACHEXIA
3↓ 30%3↓ 30% - 59
#NSCLC
3↓ 29%3↓ 29% - 60
#STANDUPTOCANCER
3↓ 28%3↓ 28%